ArticleJournal of nanobiotechnology2026
Artesunate-based macromolecular therapy attenuates neutrophilic asthma by targeting the BCAT1/Succinate/NLRP3 metabolite-immunity cascade.
Jing Gong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.